default author photo

Christopher Grainge

University of Newcastle - Department of Respiratory Medicine

Australia

SCHOLARLY PAPERS

1

DOWNLOADS

203

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Pirfenidone Solution for Inhalation (AP01) for Idiopathic Pulmonary Fibrosis (ATLAS Study): A Randomized, Open-Label, Dose-Response Trial

Number of pages: 23 Posted: 21 Oct 2021
Guy's and St Thomas' NHS Foundation Trust, The University of Manchester - Division of Infection, University of Silesia in Katowice - Department of Pneumology, Auckland District Health Board, The Prince Charles Hospital - Queensland Lung Transplant Service, Monash University - Alfred Hospital, The University of Sydney - Royal Prince Alfred Hospital, Thomayer University Hospital, The Queen Elizabeth Hospital - Respiratory Medicine Department, Medical University of Gdańsk - Department of Pneumonology, Erasmus University Medical Center Rotterdam - Department of Respiratory Medicine, University of Newcastle - Department of Respiratory Medicine, Medical University of Lodz - Department of Pneumology and Allergy, University of Washington - Interstitial Lung Disease Clinic, Avalyn Pharma, Avalyn Pharma, Avalyn Pharma, Avalyn Pharma and Avalyn Pharma
Downloads 203 (376,944)

Abstract:

Loading...

Pirfenidone, IDIOPATHIC PULMONARY FIBROSIS, IPF, pirfenidone solution for inhalation (AP01), ACTRN12618001838202, aerosol delivery, interstitial lung disease, forced vital capacity